<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/">
<channel>
<title>Press Release Service And Distribution - MarketPressRelease.com</title>
<atom:link href="http://www.marketpressrelease.com/rss2" rel="self" type="application/rss+xml" /> <link>http://www.marketpressrelease.com</link>
<description>Free press release distribution site where pr and marketing professionals can submit press release online for reaching media persons and prospective customers.</description>
<pubDate>Thu, 24 May 2012 12:45:53 +0100</pubDate>
<generator>http://www.kenovate.com</generator>
<language>en</language>
<sy:updatePeriod>daily</sy:updatePeriod>
<sy:updateFrequency>1</sy:updateFrequency>

<item>
<title>Chinas Imported Medical Device Registration</title>
<link>http://www.marketpressrelease.com/Chinas-Imported-Medical-Device-Registration-1337583534.html</link>
<pubDate>Thu, 24 May 2012 12:45:54 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Pharmaceutical]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Chinas-Imported-Medical-Device-Registration-1337583534.html</guid>
<description>an essential resource for overseas medical devices manufacturers and producers to achieve a successful application for their products entry into the Chinese medical device market,</description>
</item>
<item>
<title>How to protect your  Intellectual Property in China</title>
<link>http://www.marketpressrelease.com/How-to-protect-your-Intellectual-Property-in-China-1337039575.html</link>
<pubDate>Thu, 24 May 2012 12:45:54 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Pharmaceutical]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/How-to-protect-your-Intellectual-Property-in-China-1337039575.html</guid>
<description>an essential resource for overseas and multinational pharmaceutical companies to achieve a successful patent protection for their intellectual property in China</description>
</item>
<item>
<title>How to protect your  Intellectual Property in China</title>
<link>http://www.marketpressrelease.com/How-to-protect-your-Intellectual-Property-in-China-1337039617.html</link>
<pubDate>Thu, 24 May 2012 12:45:54 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Pharmaceutical]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/How-to-protect-your-Intellectual-Property-in-China-1337039617.html</guid>
<description>an essential resource for overseas and multinational pharmaceutical companies to achieve a successful patent protection for their intellectual property in China</description>
</item>
<item>
<title>Americans Save Up to 80 Percent on Prescription Dru*gs from Canadian Pharmacy Link</title>
<link>http://www.marketpressrelease.com/Americans-Save-Up-to-80-Percent-on-Prescription-Drugs-from-Canadian-Pharmacy-Link-1336052872.html</link>
<pubDate>Thu, 24 May 2012 12:45:54 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Pharmaceutical]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Americans-Save-Up-to-80-Percent-on-Prescription-Drugs-from-Canadian-Pharmacy-Link-1336052872.html</guid>
<description>Featuring a wide range of Health Canada approved brand name and generic dru*gs,Canadian Pharmacy Link, is committed to helping Americans purchase safe prescription dru*gs for up to 80 percent less than through U.S. pharmacies.</description>
</item>
<item>
<title>Chinas Guidebook for Pharmaceutical Patent Protection</title>
<link>http://www.marketpressrelease.com/Chinas-Guidebook-for-Pharmaceutical-Patent-Protection-1336042289.html</link>
<pubDate>Thu, 24 May 2012 12:45:54 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Pharmaceutical]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Chinas-Guidebook-for-Pharmaceutical-Patent-Protection-1336042289.html</guid>
<description>Chinas Guidebook for Pharmaceutical Patent Protection is an essential resource for overseas and multinational pharmaceutical companies to achieve a successful patent protection for their intellectual property in China.</description>
</item>
<item>
<title>Johnson &amp;amp;#38; Johnson, Pfizer, Roche, Astrazeneka, Novartis and Sanofi Aventis - All in One Roof!</title>
<link>http://www.marketpressrelease.com/Johnson-Johnson-Pfizer-Roche-Astrazeneka-Novartis-and-Sanofi-Aventis-All-in-One-Roof-1333031794.html</link>
<pubDate>Thu, 24 May 2012 12:45:54 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Pharmaceutical]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Johnson-Johnson-Pfizer-Roche-Astrazeneka-Novartis-and-Sanofi-Aventis-All-in-One-Roof-1333031794.html</guid>
<description>Why to Join Pharma Outsourcing and Procurement Summit</description>
</item>
<item>
<title>BestPriceRx.com  ideal platform for healthy and risk-free medicines</title>
<link>http://www.marketpressrelease.com/BestPriceRxcom-ideal-platform-for-healthy-and-risk-free-drugs-1335524819.html</link>
<pubDate>Thu, 24 May 2012 12:45:54 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Pharmaceutical]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/BestPriceRxcom-ideal-platform-for-healthy-and-risk-free-drugs-1335524819.html</guid>
<description>The increasing prices of prescribed medicines have been a common concern among the people as it has become difficult to purchase them at the same price.</description>
</item>
<item>
<title>InstantPharmarx Make Things Easier to Buy Medicine.</title>
<link>http://www.marketpressrelease.com/InstantPharmarx-Make-Things-Easier-to-Buy-Medicine-1335334994.html</link>
<pubDate>Thu, 24 May 2012 12:45:54 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Pharmaceutical]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/InstantPharmarx-Make-Things-Easier-to-Buy-Medicine-1335334994.html</guid>
<description>One of the most reliance websites which offers various type of medication to treat diseases is InstantPharmarx.com.</description>
</item>
<item>
<title>Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Pipeline Assessment</title>
<link>http://www.marketpressrelease.com/Chemotherapy-Induced-Nausea-and-Vomiting-CINV-Therapeutics-Pipeline-Assessment-1330434797.html</link>
<pubDate>Thu, 24 May 2012 12:45:54 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Pharmaceutical]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Chemotherapy-Induced-Nausea-and-Vomiting-CINV-Therapeutics-Pipeline-Assessment-1330434797.html</guid>
<description>Global Data\s report\&amp;quot;Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Pipeline Assessment and Market Forecasts to 2019\&amp;quot; is now available with ReportsnReports.com database</description>
</item>
<item>
<title>Are You Investing in Outsourcing?</title>
<link>http://www.marketpressrelease.com/Are-You-Investing-in-Outsourcing-1332330945.html</link>
<pubDate>Thu, 24 May 2012 12:45:54 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Pharmaceutical]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Are-You-Investing-in-Outsourcing-1332330945.html</guid>
<description>Dr Karl Manrodt, Professor of Logistics in the Department of Management &amp;amp;#38; Author of Vested Outsourcing, Georgia Southern University   US will be one of the key speakers of the Pharma Outsourcing and Procurement Summit 2012 in Germany.</description>
</item>
<item>
<title>Micro Labs, Sun Pharma, Cipla &amp;amp;#38; Glenmark are in race for coveted Leadership Award in Healthcare</title>
<link>http://www.marketpressrelease.com/Micro-Labs-Sun-Pharma-Cipla-Glenmark-are-in-race-for-coveted-Leadership-Award-in-Healthcare-1329968478.html</link>
<pubDate>Thu, 24 May 2012 12:45:54 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Pharmaceutical]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Micro-Labs-Sun-Pharma-Cipla-Glenmark-are-in-race-for-coveted-Leadership-Award-in-Healthcare-1329968478.html</guid>
<description>3rd Annual Indian Affairs Business Leadership Awards 2011 Will Test The Leadership Of Domestic Pharma Majors Micro Labs, Sun Pharma, Cipla &amp;amp;#38; Glenmark For The Coveted Indias Most Valuable Pharmaceutical Company</description>
</item>
<item>
<title>The Dates of World Drug Delivery and Formulation Summit Asia Have Now Been Set for 17th-18th Oct2012</title>
<link>http://www.marketpressrelease.com/The-Dates-of-World-Drug-Delivery-and-Formulation-Summit-Asia-Have-Now-Been-Set-for-17th-18th-Oct2012-1327596095.html</link>
<pubDate>Thu, 24 May 2012 12:45:54 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Pharmaceutical]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/The-Dates-of-World-Drug-Delivery-and-Formulation-Summit-Asia-Have-Now-Been-Set-for-17th-18th-Oct2012-1327596095.html</guid>
<description>This summit will bring together over 150+ senior level drug delivery, biologic and pharma formulation directors to explore and profit from Asias prospering growth.</description>
</item>
<item>
<title>The Pharma Outsourcing and Procurement Summit 2012 Programme Is Now Live!</title>
<link>http://www.marketpressrelease.com/The-Pharma-Outsourcing-and-Procurement-Summit-2012-Programme-Is-Now-Live-1327595764.html</link>
<pubDate>Thu, 24 May 2012 12:45:54 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Pharmaceutical]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/The-Pharma-Outsourcing-and-Procurement-Summit-2012-Programme-Is-Now-Live-1327595764.html</guid>
<description>This summit will bring together over 100+ senior level professionals to address the urgent need for pharma to identify and locate the best outsourcing partnerships and solutions to stay competitive in an uncertain climate.</description>
</item>
<item>
<title>Biosimilar Insulin Products in the US to Grow at a CAGR of 74 Percent over the Period 2013-2020</title>
<link>http://www.marketpressrelease.com/Biosimilar-Insulin-Products-in-the-US-to-Grow-at-a-CAGR-of-74-Percent-over-the-Period-2013-2020-1327483802.html</link>
<pubDate>Thu, 24 May 2012 12:45:54 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Pharmaceutical]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Biosimilar-Insulin-Products-in-the-US-to-Grow-at-a-CAGR-of-74-Percent-over-the-Period-2013-2020-1327483802.html</guid>
<description>Lantus is expected to be the most lucrative target for biosimilar manufacturers and account for 71% of the total biosimilar Insulin sales by 2020.</description>
</item>
<item>
<title>Bristol-Myers Squibb To Acquire Inhibitex</title>
<link>http://www.marketpressrelease.com/Bristol-Myers-Squibb-To-Acquire-Inhibitex-1326055221.html</link>
<pubDate>Thu, 24 May 2012 12:45:54 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Pharmaceutical]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Bristol-Myers-Squibb-To-Acquire-Inhibitex-1326055221.html</guid>
<description>Strategic Acquisition Supports Long-Term Growth Potential of the Company
Builds on Companys Strong Legacy and Commitment in Virology
Enhances Companys Broad HCV Portfolio with Addition of INX-189, a potent NS5B Nucleotide</description>
</item>
<item>
<title>Price Control of Medicines are detrimental for Indias Healthcare Growth Story &amp;amp;#38; Drives Kewal Handa</title>
<link>http://www.marketpressrelease.com/Price-Control-of-Medicines-are-detrimental-for-Indias-Healthcare-Growth-Story-Drives-Kewal-Handa-1325824501.html</link>
<pubDate>Thu, 24 May 2012 12:45:54 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Pharmaceutical]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Price-Control-of-Medicines-are-detrimental-for-Indias-Healthcare-Growth-Story-Drives-Kewal-Handa-1325824501.html</guid>
<description>Health Insurance &amp;amp;#38; Availability should be the focus &amp;amp;#38; not the Govts Draft Policy. Canada &amp;amp;#38; Philippines growth is due to non-Price Control.</description>
</item>
<item>
<title>Ranbaxy Global Consumer Healthcare &amp;amp;#38; Aanjaneya Lifecare Declared Winners at Pharma Awards 2011</title>
<link>http://www.marketpressrelease.com/Ranbaxy-Global-Consumer-Healthcare-Aanjaneya-Lifecare-Declared-Winners-at-Pharma-Awards-2011-1324003943.html</link>
<pubDate>Thu, 24 May 2012 12:45:54 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Pharmaceutical]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Ranbaxy-Global-Consumer-Healthcare-Aanjaneya-Lifecare-Declared-Winners-at-Pharma-Awards-2011-1324003943.html</guid>
<description>Kewal Handa Of Pfizer &amp;amp;#38; Aditi Kare Of Indoco Are Business Leaders While Pfizer, Abbott, GSK, Microlabs, Elder Pharmaceuticals, Fortis, Bharat Biotech, Adriot Are Biomed Among Those Win The Race In Important Categories.</description>
</item>
<item>
<title>Watch Pfizer Chief Kewal Handa As He Speaks On His Perspectives of The  Draft Pharma Pricing</title>
<link>http://www.marketpressrelease.com/Watch-Pfizer-Chief-Kewal-Handa-As-He-Speaks-On-His-Perspectives-of-The-Draft-Pharma-Pricing-1323060670.html</link>
<pubDate>Thu, 24 May 2012 12:45:54 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Pharmaceutical]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Watch-Pfizer-Chief-Kewal-Handa-As-He-Speaks-On-His-Perspectives-of-The-Draft-Pharma-Pricing-1323060670.html</guid>
<description>Indian Healthcare Industrys leading voice &amp;amp;#38; one of the most respected name in the pharmaceutical sector, Mr Kewal Handa who strategies worlds leading drugmaker Pfizer in Indian operation will be speaking exclusively via televised tape</description>
</item>
<item>
<title>Ventura Pharamcacy - ABC Compounding pharmacy</title>
<link>http://www.marketpressrelease.com/Ventura-Pharamcacy-ABC-Compounding-pharmacy-1322802680.html</link>
<pubDate>Thu, 24 May 2012 12:45:54 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Pharmaceutical]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Ventura-Pharamcacy-ABC-Compounding-pharmacy-1322802680.html</guid>
<description>ABC Compounding Pharmacy, we aim to prove how compounding medication can help patients lead happier and healthier lives.</description>
</item>
<item>
<title>New Report Suggests that Roche is Less Exposed to Biosimilars than Amgen</title>
<link>http://www.marketpressrelease.com/New-Report-Suggests-that-Roche-is-Less-Exposed-to-Biosimilars-than-Amgen-1322548418.html</link>
<pubDate>Thu, 24 May 2012 12:45:54 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Pharmaceutical]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/New-Report-Suggests-that-Roche-is-Less-Exposed-to-Biosimilars-than-Amgen-1322548418.html</guid>
<description>Excluding Mabthera, Roches other brands will face biosimilar competition only after 2019. As a result, the company will suffer most of its brand erosion post-2020.</description>
</item>
</channel>
</rss>

